Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Sun Pharmaceutical Industries Community
NSEI:SUNPHARMA Community
1
Narratives
written by author
0
Comments
on narratives written by author
23
Fair Values set
on narratives written by author
Community Investing Ideas
Sun Pharmaceutical Industries
Popular
Undervalued
Overvalued
Sun Pharmaceutical Industries
AN
AnalystConsensusTarget
Consensus Narrative from 37 Analysts
Specialty Therapies And Emerging Markets Will Unlock Future Potential
Key Takeaways Expansion in specialty and innovative products, alongside emerging markets penetration, is driving higher-margin revenue growth and strengthening market presence. Strategic R&D investments and operational efficiencies are fueling a robust product pipeline, supporting sustained profitability and long-term competitive advantages.
View narrative
₹1.94k
FV
18.3% undervalued
intrinsic discount
9.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
4 days ago
author updated this narrative
Your Valuation for
SUNPHARMA
SUNPHARMA
Sun Pharmaceutical Industries
Your Fair Value
₹
Current Price
₹1.59k
15.8% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
838b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹837.8b
Earnings ₹161.6b
Advanced
Set Fair Value